EUVIMEDPoznaj EUVIMED
Übersichtsarbeit

Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation

Negar Paknia iD, Hadis Soltanimehr iD, Hadieh Rahbar Kafshboran iD, Soheila Ghasemi iD

ChemMedChem · 2026-11-12 · 21 (21)

DOI: 10.1002/cmdc.70552 ↗

At a glance

Übersichtsarbeit in ChemMedChem, published online on 2026-11-05. Written by Negar Paknia and 3 co-authors. Institution: Department of Chemistry, College of Sciences, Shiraz University, Shiraz, Iran. Major MEDLINE topics: Hydrogels, Neoplasms, Antineoplastic Agents, Drug Design. 366 references.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Stimuli‐responsive hydrogels (SRHs) are versatile soft biomaterials capable of dynamically responding to environmental cues, enabling controlled and site‐specific drug release for cancer therapy. Advances in polymer chemistry and nanotechnology have facilitated the development of SRHs that respond to tumor‐associated stimuli, including pH, redox potential, temperature, enzymatic activity, light, and glucose gradients. Among these systems, pH‐ and redox‐responsive hydrogels exploit the acidic and oxidative tumor microenvironment, while thermo‐ and photo‐responsive platforms enable spatiotemporal regulation of therapeutic payloads. Recent studies have demonstrated highly efficient, stimulus‐triggered drug release and enhanced therapeutic outcomes in vitro and in vivo. This review systematically examines the design strategies, molecular mechanisms, and structure–function relationships governing SRHs in oncology. Emerging hydrogel architectures—such as injectable systems, hybrid nanocomposites, and multifunctional platforms integrating targeting or imaging capabilities—are critically discussed. Importantly, the review addresses key challenges in clinical translation, including biocompatibility, scalability, regulatory considerations, and reproducibility. Finally, future perspectives are outlined, highlighting the potential of artificial intelligence‐assisted material design, computational modeling, and wearable or implantable bioelectronic interfaces for real‐time monitoring and adaptive cancer therapy. By integrating mechanistic insights with translational and regulatory viewpoints, this review aims to guide the rational development of next‐generation smart hydrogel therapeutics for clinical oncology.

Subjects

MeSH terms (MEDLINE)

HydrogelsNeoplasmsAntineoplastic AgentsDrug DesignHumansAnimalsTumor MicroenvironmentDrug Carriers

Author keywords

AI‐assisted hydrogel designcancer therapycontrolled drug deliverystimuli‐responsive hydrogelstumor microenvironment

Substances

HydrogelsAntineoplastic AgentsDrug Carriers

Authors and institutions

  • Department of Chemistry, College of Sciences, Shiraz University, Shiraz, Iran.

ORCID profiles: Negar Paknia, Hadis Soltanimehr, Hadieh Rahbar Kafshboran, Soheila Ghasemi

Cite

APA

Paknia, N., Soltanimehr, H., Kafshboran, H. R., & Ghasemi, S. (2026). Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70552

Vancouver

Paknia N, Soltanimehr H, Kafshboran HR, Ghasemi S. Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70552

BibTeX
@article{Paknia2026,
  author = {Paknia, Negar and Soltanimehr, Hadis and Kafshboran, Hadieh Rahbar and Ghasemi, Soheila},
  title = {Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {21},
  doi = {10.1002/cmdc.70552}
}
Start for free →